TY  - JOUR
AU  - Fuso, Paola
AU  - Di Salvatore, Mariantonietta
AU  - Santonocito, Concetta
AU  - Guarino, Donatella
AU  - Autilio, Chiara
AU  - Mulè, Antonino
AU  - Arciuolo, Damiano
AU  - Rinninella, Antonina
AU  - Mignone, Flavio
AU  - Ramundo, Matteo
AU  - Di Stefano, Brunella
AU  - Orlandi, Armando
AU  - Capoluongo, Ettore
AU  - Nicolotti, Nicola
AU  - Franceschini, Gianluca
AU  - Martín Sánchez, Alejandro
AU  - Tortora, Giampaolo
AU  - Scambia, Giovanni
AU  - Barone, Carlo
AU  - Cassano, Alessandra
PY  - 2021
DO  - 10.3390/jpm11080816
SN  - 2075-4426
UR  - https://hdl.handle.net/20.500.14352/4934
T2  - Journal of Personalized Medicine
AB  - Background: The aim of this study is to identify miRNAs able to predict the outcomes in breast cancer patients after neoadjuvant chemotherapy (NAC).Patients and methods: We retrospectively analyzed 24 patients receiving NAC and not reaching pathologic...
LA  - eng
M2  - 816
PB  - MPDI
KW  - subtypes breast cancer
KW  - miRNAs
KW  - breast cancer treatment
KW  - chemotherapy
KW  - integrated therapies
KW  - next-generation-sequencing
KW  - target therapy
KW  - precision medicine
KW  - personalized medicine
TI  - Let-7a-5p, miR-100-5p, miR-101-3p, and miR-199a-3p Hyperexpression as Potential Predictive Biomarkers in Early Breast Cancer Patients
TY  - journal article
VL  - 11
ER  -